Research Paper Volume 16, Issue 6 pp 5545—5566
A pyrimidine metabolism-related signature for prognostic and immunotherapeutic response prediction in hepatocellular carcinoma by integrating analyses
Figure 8. Further exploration of the immune landscape in PMRS. (A–D) TIDE analysis of the two risk groups. (E–H) The relation between the expression of four model genes and immune cell infiltration. (I–L) The relation between the mutation landscape of four model genes and immune cell infiltration. (*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001).